Thomas Mika Deepak Vangala Matthias Eckhardt Paul La Rosée Christoph Lange Kai Lehmberg Charlotte Wohlschläger Saskia Biskup Ilka Fuchs Jasmin Mann Stephan Ehl Klaus Warnatz Roland Schroers
10.3389/fimmu.2021.682934
Front Immunol
2021 May 10;12:682934.
cd107a gata2 allogeneic hematopoietic stem cell transplantation hemophagocytic lymphohistiocytosis non-tuberculous mycobacteriosis
CC BY
https://pubmed.ncbi.nlm.nih.gov/34040617/
GATA2 Transcription Factor / genetics Genetic Predisposition to Disease Genetic Variation Lymphohistiocytosis, Hemophagocytic / diagnosis Lymphohistiocytosis, Hemophagocytic / genetics Mycobacterium Infections, Nontuberculous / diagnosis Mycobacterium Infections, Nontuberculous / genetics
GATA2 Transcription Factor / genetics Genetic Predisposition to Disease Genetic Variation Lymphohistiocytosis, Hemophagocytic / diagnosis Lymphohistiocytosis, Hemophagocytic / genetics Mycobacterium Infections, Nontuberculous / diagnosis Mycobacterium Infections, Nontuberculous / genetics Case Reports Biomarkers Disease Management Female Genetic Association Studies Hematopoietic Stem Cell Transplantation Humans Immunophenotyping Killer Cells, Natural / immunology Killer Cells, Natural / metabolism Lymphohistiocytosis, Hemophagocytic / therapy Male Mycobacterium Infections, Nontuberculous / therapy Positron Emission Tomography Computed Tomography Treatment Outcome Biomarkers GATA2 Transcription Factor GATA2 protein, human
PMC8143047
34040617
Case Report: Hemophagocytic Lymphohistiocytosis and Non-Tuberculous Mycobacteriosis Caused by a Novel GATA2 Variant
2021